Neurothera Labs Inc.
NTLX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 680.00K | 768.00K | 856.00K | 903.00K | 927.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 680.00K | 768.00K | 856.00K | 903.00K | 927.00K |
| Cost of Revenue | 196.00K | 210.50K | 225.00K | 514.00K | 535.00K |
| Gross Profit | 484.00K | 557.50K | 631.00K | 389.00K | 392.00K |
| SG&A Expenses | 2.50M | 2.03M | 1.57M | 1.10M | 1.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.48M | 5.02M | 4.55M | 4.27M | 4.37M |
| Operating Income | -4.80M | -4.25M | -3.69M | -3.37M | -3.44M |
| Income Before Tax | -6.36M | -5.83M | -5.30M | -4.69M | -4.77M |
| Income Tax Expenses | 19.00K | 19.00K | 19.00K | 5.00K | 5.00K |
| Earnings from Continuing Operations | -6.38 | -5.85 | -5.32 | -4.70 | -4.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 307.00K | 315.00K | 323.00K | 1.27M | 1.27M |
| Net Income | -6.08M | -5.54M | -5.00M | -3.43M | -3.50M |
| EBIT | -4.80M | -4.25M | -3.69M | -3.37M | -3.44M |
| EBITDA | -4.62M | -4.06M | -3.50M | -3.13M | -3.17M |
| EPS Basic | -1.07 | -1.03 | -0.98 | -0.85 | -0.74 |
| Normalized Basic EPS | -0.56 | -0.53 | -0.51 | -0.17 | -0.17 |
| EPS Diluted | -1.07 | -1.03 | -0.98 | -0.85 | -0.74 |
| Normalized Diluted EPS | -0.56 | -0.53 | -0.51 | -0.17 | -0.17 |
| Average Basic Shares Outstanding | 19.46M | 17.28M | 15.11M | 13.56M | 13.56M |
| Average Diluted Shares Outstanding | 23.98M | 21.80M | 19.63M | 18.09M | 13.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |